Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 3868Neoplasms 2995Prostatic Neoplasms 1756Colorectal Neoplasms 1431Lung Neoplasms 1334Motor Activity 807Head and Neck Neoplasms 687Pancreatic Neoplasms 664Colonic Neoplasms 655Uterine Cervical Neoplasms 653Carcinoma, Hepatocellular 634Carcinoma, Non-Small-Cell Lung 632Rectal Neoplasms 571Stomach Neoplasms 547Brain Neoplasms 487Ovarian Neoplasms 443Pain 420Anxiety Disorders 420Neoplasm Metastasis 385Esophageal Neoplasms 384Polycystic Ovary Syndrome 376Precursor Cell Lymphoblastic Leukemia-Lymphoma 354Urinary Bladder Neoplasms 352Fatigue 341Melanoma 324Multiple Myeloma 323Lymphoma 306Depression 306Endometrial Neoplasms 291Liver Neoplasms 280

Interventions

Electrocardiography 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Brugada Syndrome × Clear all
NCT07364656 2026-01-23

Analysis of the Presence and Cardiac Functional Effects of Anti-NaV1.5 Autoantibodies in Patients With Metastatic Tumors

IRCCS Policlinico S. Donato

Phase NA Not yet recruiting
196 enrolled
Gastrointestinal

Colonic Neoplasms, Brugada Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡